EPISODE · Feb 1, 2021 · 50 MIN
Mark DePristo - designing antibodies with machine learning
from The Bioinformatics CRO Podcast
We talk with Mark DePristo, founder and CEO of BigHat Biosciences, about building better antibody therapeutics using machine learning, overcoming the fear of failure, and the pros and cons of working in academia, for large companies like Google, and at a biotech start up. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics. https://www.bioinformaticscro.com/
NOW PLAYING
Mark DePristo - designing antibodies with machine learning
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m